Loading viewer...
investor_presentation
Format: PDF investor_presentation
Universal Biosensors H1 2024 investor presentation highlights 19% sales growth and improved gross margins year-over-year. Key performance drivers include 73% growth in Xprecia sales and 76% revenue growth in HRL, though Sentia sales declined 8%. The company reported improving profitability with positive underlying NPAT and expanding margins across the portfolio.
investor_presentation
30 Pages
Bonneville Power Administration
investor_presentation
DZ BANK Group
Brookfield Asset Management 2016 Corporate Profile
investor_presentationinvestor_presentation
24 Pages
Brookfield Asset Management
investor_presentation
Xanadu Mining